Literature DB >> 28639210

[Oxytocin and the mechanisms of alcohol dependence].

Till Faehrmann1, Gerald Zernig2, Sergei Mechtcheriakov3.   

Abstract

One of the crucial purposes of treating alcohol-dependent patients is to enhance their ability to stay abstinent after detoxification therapy. Anxiety and stress vulnerability are the main factors provoking alcohol craving and relapse. In the first months of abstinence, alcohol-dependent patients frequently show sleep disturbances, irritability and depression, indicating chronic activation of stress pathways. In addition, the loss of confidence in interpersonal interactions results in social withdrawal and reduced willingness to participate in therapeutic programs.Current research shows that the peptide hormone oxytocin exerts substantial anxiolytic effects and facilitates prosocial behavior. Oxytocin can be safely applied as intranasal preparation. Oxytocin acts by inhibiting the effects of the corticotropin-releasing factor on GABAergic interneurons in the amygdala and paraventricular nucleus of hypothalamus.Recent research strongly suggests that application of oxytocin may beneficially influence the mechanisms of relapse and craving by reduction of anxiety, stress vulnerability and social withdrawal in abstinent alcohol-dependent patients.This article reviews neurobiological mechanisms of oxytocin effects on stress-related pathways and discusses the potential use of oxytocin in the treatment of alcohol addiction.

Entities:  

Keywords:  Alcohol dependence; Amygdala; Anxiety; Oxytocin; Stress

Mesh:

Substances:

Year:  2017        PMID: 28639210     DOI: 10.1007/s40211-017-0229-y

Source DB:  PubMed          Journal:  Neuropsychiatr        ISSN: 0948-6259


  55 in total

1.  Evoked axonal oxytocin release in the central amygdala attenuates fear response.

Authors:  H Sophie Knobloch; Alexandre Charlet; Lena C Hoffmann; Marina Eliava; Sergey Khrulev; Ali H Cetin; Pavel Osten; Martin K Schwarz; Peter H Seeburg; Ron Stoop; Valery Grinevich
Journal:  Neuron       Date:  2012-02-09       Impact factor: 17.173

2.  Intranasal Oxytocin Mechanisms Can Be Better Understood, but Its Effects on Social Cognition and Behavior Are Not to Be Sniffed At.

Authors:  Daniel S Quintana; Joshua D Woolley
Journal:  Biol Psychiatry       Date:  2015-07-02       Impact factor: 13.382

Review 3.  Potential for oxytocin use in children and adolescents with mental illness.

Authors:  Elisabeth Netherton; Dawnelle Schatte
Journal:  Hum Psychopharmacol       Date:  2011-07-12       Impact factor: 1.672

4.  Large intercalated neurons of amygdala relay noxious sensory information.

Authors:  Thomas C M Bienvenu; Daniela Busti; Benjamin R Micklem; Mahnaz Mansouri; Peter J Magill; Francesco Ferraguti; Marco Capogna
Journal:  J Neurosci       Date:  2015-02-04       Impact factor: 6.167

Review 5.  New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata.

Authors:  G F Alheid; L Heimer
Journal:  Neuroscience       Date:  1988-10       Impact factor: 3.590

Review 6.  Bridging the gap between GPCR activation and behaviour: oxytocin and prolactin signalling in the hypothalamus.

Authors:  Erwin H van den Burg; Inga D Neumann
Journal:  J Mol Neurosci       Date:  2010-09-24       Impact factor: 3.444

Review 7.  Alcoholism: allostasis and beyond.

Authors:  George F Koob
Journal:  Alcohol Clin Exp Res       Date:  2003-02       Impact factor: 3.455

Review 8.  A role for brain stress systems in addiction.

Authors:  George F Koob
Journal:  Neuron       Date:  2008-07-10       Impact factor: 17.173

9.  Differential effects of baclofen and oxytocin on the increased ethanol consumption following chronic psychosocial stress in mice.

Authors:  Sebastian Peters; David A Slattery; Peter J Flor; Inga D Neumann; Stefan O Reber
Journal:  Addict Biol       Date:  2012-11-06       Impact factor: 4.280

10.  Differential stress-induced neuronal activation patterns in mouse lines selectively bred for high, normal or low anxiety.

Authors:  Patrik Muigg; Sandra Scheiber; Peter Salchner; Mirjam Bunck; Rainer Landgraf; Nicolas Singewald
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

View more
  2 in total

Review 1.  Therapeutic Potential of Oxytocin in Atherosclerotic Cardiovascular Disease: Mechanisms and Signaling Pathways.

Authors:  Ping Wang; Stephani C Wang; Haipeng Yang; Chunmei Lv; Shuwei Jia; Xiaoyu Liu; Xiaoran Wang; Dexin Meng; Danian Qin; Hui Zhu; Yu-Feng Wang
Journal:  Front Neurosci       Date:  2019-05-21       Impact factor: 4.677

Review 2.  Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review.

Authors:  Pascal Valentin Fischler; Michael Soyka; Erich Seifritz; Jochen Mutschler
Journal:  Front Pharmacol       Date:  2022-10-03       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.